WallachBeth Capital
Tracked across 1 events · 6 articles · First seen Aug 13, 2026 · Last active Aug 14, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
BioAffinity Technologies, Inc., a biotechnology company focused on noninvasive diagnostics and early cancer detection, announced the closing of its previously announced private placement priced at-the-market under Nasdaq rules. The offering involved the sale of pre-funded…
Impact: WallachBeth Capital acted as the sole placement agent for the offering, earning fees and strengthening its relationship with BioAffinity Technologies. The transaction adds to its portfolio of healthcare capital markets services.
Aug 13, 2026 · 6 articles
80
WallachBeth Capital acted as placement agent BioAffinity TechnologiesbioAffinity Technologies...
ERGEN INTELLIGENCE
Track WallachBeth Capital live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard